Munafa Stock Market Course + Intraday & FNO calls 
BAFNAPH NEWS why is Bafna Pharmaceuticals Ltd price falling or rising
BAFNAPH NEWS reasons for why stock price of Bafna Pharmaceuticals Ltd is falling or rising
BAFNAPH Bafna Pharmaceuticals is falling or rising technical reasons
Technical analysis forecast of Bafna Pharmaceuticals Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Bafna Pharmaceuticals BAFNAPH at this time. Stock is rising and might rise more.
It appears as if Bafna Pharmaceuticals BAFNAPH gave a large move recently.
Stock of Bafna Pharmaceuticals (BAFNAPH) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!
My analysis of Bafna Pharmaceuticals is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if Bafna Pharmaceuticals stays above 164.9, but if it comes below 164.9, then a intra day sell could be more profitable.
If you take a sell trade below 164.9, then use 164.9 as stoploss and 147.39 as target. However if you take a buy trade in Bafna Pharmaceuticals, then use 164.9 as stoploss and 185.9 as target.
BAFNAPH Bafna Pharmaceuticals is falling or rising NEWS fundamental reasons
Company Announcement Bafna Pharmaceuticals Limited has informed the Exchange about retirement of Mr. Navin Kumar (DIN: 08778662) as an Independent Director of the Company upon completion of his first term, with effect from close of business hours on June 22, 2026 - NEWS as on 2026-06-23
Company Announcement Bafna Pharmaceuticals Limited has submitted to the Exchange, the Audited financial results for the Quarter and Year ended March 31, 2026. - NEWS as on 2026-06-01
Board Meeting to discuss Financial Results To consider and approve the Audited Financial Results for the Quarter and Year ended March 31, 2026 - NEWS as on 2026-05-22
Company Announcement - NEWS as on 2026-05-22
Company Announcement Bafna Pharmaceuticals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. - NEWS as on 2026-05-12
Company Announcement SRJR Lifesciences LLP has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. - NEWS as on 2026-05-05
Company Announcement Bafna Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended March 31, 2026. - NEWS as on 2026-04-13
Company Announcement Bafna Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on March 27, 2026, in which the Board of Directors has inter-alia considered and approved: (i). The appointment of M/s. K. S. Rao & Co., Chartered Accountants, - NEWS as on 2026-03-27
Company Announcement Bafna Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 - NEWS as on 2026-03-27
Company Announcement Bafna Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication for the Unaudited Financial Results of the Company for the Quarter and Nine-Months ended December 31, 2025 as published in "Business Standard" and "Makkal Kural" on - NEWS as on 2026-02-16
Company Announcement Bafna Pharmaceuticals Limited has submitted to the Exchange, the outcome of the Board Meeting held on February 11, 2026 along with the Unaudited financial results and Limited Review Report for the Quarter and Nine Months ended December 31, 2025. - NEWS as on 2026-02-12
Board Meeting to discuss Financial Results To consider and approve the Unaudited Financial Results for the Quarter ended December 31, 2025 - NEWS as on 2026-02-05
More announcements and NEWS
BAFNAPH Bafna Pharmaceuticals Ltd current price & indicator signals
Recent prices of BAFNAPH Bafna Pharmaceuticals Ltd are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 09 Tue Jun 2026 | 174.58 | 174.58 to 213.36 | -10% | 50.35 times |
| 08 Mon Jun 2026 | 193.97 | 187.35 to 193.97 | 10% | 2.44 times |
| 05 Fri Jun 2026 | 176.34 | 169.00 to 176.34 | 10% | 1.58 times |
| 04 Thu Jun 2026 | 160.31 | 160.31 to 160.31 | 5% | 0.72 times |
| 03 Wed Jun 2026 | 152.68 | 152.68 to 152.68 | 5% | 0.41 times |
| 02 Tue Jun 2026 | 145.41 | 144.30 to 145.41 | 5% | 1.16 times |
| 01 Mon Jun 2026 | 138.49 | 134.00 to 138.49 | 5% | 1.53 times |
| 29 Fri May 2026 | 131.90 | 131.10 to 135.50 | 1.54% | 0.16 times |
| 27 Wed May 2026 | 129.90 | 125.00 to 136.66 | -0.2% | 0.65 times |
| 26 Tue May 2026 | 130.16 | 129.05 to 139.40 | -4.18% | 1.09 times |
| 25 Mon May 2026 | 135.84 | 135.50 to 140.80 | 0.6% | 0.25 times |
| 22 Fri May 2026 | 135.03 | 133.01 to 142.33 | -0.6% | 0.45 times |
Videos related to: BAFNAPH NEWS why is Bafna Pharmaceuticals Ltd price falling or rising
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
